Three articles have very recently appeared that are of especial relevance to the causes of dementia demonstrate an increased risk of subsequent senile dementia (SD) development in patients with 4 acute varicella zoster (herpes zoster) infection. These articles present data highly relevant to the 5 third, and most important, paper -by Tzeng et al., published online in the journal 6 Neurotherapeutics at the end of February 2018. These authors report that infection with a different 7 herpes virus, herpes simplex virus type 1 (HSV1), leads to a similarly increased risk of later 8 developing SD. Further, when the authors looked at patients treated aggressively with antiherpetic 9 medications at the time, the relative SD risk was reduced by a factor of 10. It should be stressed that 10 no investigations were made on subjects already suffering from SD, and that those treated were the 11 few rare cases severely affected by HSV. Nonetheless, antiherpetic medication prevented later SD 12 development in 90% of their study group. These articles provide the first population evidence for a 13 causal link between herpes virus infection and senile dementia. The first two studies focus on VZV, a herpes virus that causes chickenpox and which, like HSV1, In this study the incidence of SD was only marginally increased in the VZV patients (risk ratio 1.11, VZV sequences per sample) [7] . However, the finding that AVT (the agents used by Chen et al. 25 block the replication of both VZV and HSV, but have no effect on the latent viruses) reduces the general VZV infection (1.11, Chen et al. [6] ). The effect was largely restricted to HSV1 infections, 20 although a small risk associated with HSV2 was also noted. When SD was subtyped into AD and 21 vascular dementia, similar risk profiles were found in both cases. based on the assumption that passage generally occurs in middle age when the immune system 1 starts to decline. The Taiwan study group (≥50 years of age) subjects were selected as having newly 2 diagnosed HSV infection, although whether they had newly acquired infection or reactivation of 3 existing (latent) infection is uncertain. In either case, however, AVT would greatly reduce viral 4 replication in the periphery, thereby reducing the likelihood that peripheral virus travels to the brain.
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Because AVT treatment might only delay (rather than prevent) transmission to the brain, extending 6 the Taiwan survey for 5-10 years could determine whether SD cases later increase in the treated 7 cohort. Investigation to seek HSV1 DNA in the brain post mortem of any such subsequent cases of 8 dementia, and of those who remained free of the disease, might help to elucidate the situation. To our knowledge, these three papers provide the first population-level evidence for a link between Although the antiviral agents employed are very specific against the Herpesviridae, the three papers 16 do not yet prove a causal link between infection with a specific virus and SD. The key study by 17 Tzeng et al. [9] has also some limitations that we highlight below. Fourth, the incidence of SD in the study group (acute HSV infection; n = 8362) represents a very 2 small proportion of total SD cases. In a population of 24 million (Taiwan), making some 3 assumptions regarding mean age and SD incidence in the general population, the calculated number 4 of SD cases in this group would represent at most well under 1% of all SD cases in that country. In 5 the absence of further data it is not possible to know whether viral infection might be a contributory 6 factor to SD development more generally, or is likely to be responsible for only a minority of SD 7 cases. It must be stressed that these studies give no information about subjects who already suffer from 17 SD: the data apply only to AVT in a small minority group applied well before any obvious 
